TCG Crossover Management, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001839948 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 14, 2025

Total Value: $876M (100.0% shares, 0.0% debt)

Holdings (37)

CGON CG ONCOLOGY INC 10.9%
Value $95.43M Shares 3,670,206 Est. Cost $40.67 Unrealized -40.8%
TNGX TANGO THERAPEUTICS INC 6.3%
Value $54.97M Shares 10,736,000 Est. Cost $4.64 Unrealized -46.8%
COGT COGENT BIOSCIENCES INC 5.7%
Value $50M Shares 6,964,375 Est. Cost $9.05 Unrealized -38.7%
OCUL OCULAR THERAPEUTIX INC 5.6%
Value $49.36M Shares 5,319,148 Est. Cost $7.10 Unrealized +10.3%
CIDARA THERAPEUTICS INC 5.6%
Value $49M Shares 1,005,901 Est. Cost $25.94 Unrealized
ABVX ABIVAX SA AMERICAN DEPOSITARY SHARES 5.3%
Value $46.33M Shares 6,056,596 Est. Cost $12.76 Unrealized
AMLX AMYLYX PHARMACEUTICALS INC 4.4%
Value $38.1M Shares 5,943,812 Est. Cost $2.53 Unrealized +91.9%
CNTA CENTESSA PHARMACEUTICALS PLC 4.3%
Value $37.99M Shares 2,890,816 Est. Cost $7.22 Unrealized
FULC FULCRUM THERAPEUTICS INC 4.1%
Value $36.12M Shares 5,250,000 Est. Cost $7.42 Unrealized -27.9%
DYN DYNE THERAPEUTICS INC 4.1%
Value $35.86M Shares 3,766,660 Est. Cost $14.96 Unrealized -26.4%
EYPT EYEPOINT PHARMACEUTICALS INC 3.8%
Value $33.62M Shares 3,572,335 Est. Cost $10.51 Unrealized -34.3%
UPB UPSTREAM BIO INC 3.5%
Value $30.76M Shares 2,801,763 Est. Cost $22.33 Unrealized -58.6%
SVRA SAVARA INC 3.2%
Value $28.19M Shares 12,362,205 Est. Cost $3.73 Unrealized -27.2%
DNTH DIANTHUS THERAPEUTICS INC 3.2%
Value $27.98M Shares 1,501,624 Est. Cost $25.71 Unrealized -27.0%
TYRA TYRA BIOSCIENCES INC 3.2%
Value $27.73M Shares 2,898,103 Est. Cost $12.78 Unrealized -25.6%
IRON DISC MEDICINE INC 2.8%
Value $24.64M Shares 465,257 Est. Cost $33.98 Unrealized +38.2%
TOURMALINE BIO INC 2.7%
Value $23.63M Shares 1,477,593 Est. Cost $25.14 Unrealized
AGIO Agios Pharmaceuticals, Inc. 2.6%
Value $23.18M Shares 697,003 Est. Cost $30.31 Unrealized 0.0%
GPCR STRUCTURE THERAPEUTICS INC 2.5%
Value $22.05M Shares 1,063,000 Est. Cost $43.45 Unrealized
XNCR XENCOR INC 2.2%
Value $19.27M Shares 2,452,138 Est. Cost $18.82 Unrealized -52.3%
SLN SILENCE THERAPEUTICS PLC 2.0%
Value $17.59M Shares 3,033,560 Est. Cost $14.21 Unrealized
SLNO SOLENO THERAPEUTICS INC 1.8%
Value $15.6M Shares 186,250 Est. Cost $47.87 Unrealized +56.3%
ASTRIA THERAPEUTICS INC 1.7%
Value $14.8M Shares 2,761,861 Est. Cost $14.07 Unrealized
RAPT RAPT Therapeutics, Inc. 1.5%
Value $13.09M Shares 1,636,275 Est. Cost $7.63 Unrealized 0.0%
THIRD HARMONIC BIO INC 1.2%
Value $10.4M Shares 1,915,424 Est. Cost $13.43 Unrealized
ELVN Enliven Therapeutics, Inc. 1.1%
Value $9.99M Shares 498,000 Est. Cost $18.93 Unrealized 0.0%
MBX MBX BIOSCIENCES INC 0.8%
Value $7.417M Shares 650,000 Est. Cost $22.87 Unrealized -55.5%
NKTR NEKTAR THERAPEUTICS 0.8%
Value $6.891M Shares 266,666 Est. Cost $11.24 Unrealized 0.0%
VTGN VISTAGEN THERAPEUTICS INC 0.6%
Value $5.353M Shares 2,676,580 Est. Cost $3.41 Unrealized -33.4%
KOD KODIAK SCIENCES INC 0.5%
Value $4.273M Shares 1,145,538 Est. Cost $4.16 Unrealized -15.0%
KURA KURA ONCOLOGY INC 0.5%
Value $4.242M Shares 735,184 Est. Cost $14.54 Unrealized -57.9%
TRDA ENTRADA THERAPEUTICS INC 0.4%
Value $3.931M Shares 584,955 Est. Cost $17.12 Unrealized
ADVERUM BIOTECHNOLOGIES INC 0.4%
Value $3.862M Shares 1,796,482 Est. Cost $7.02 Unrealized
AVTX AVALO THERAPEUTICS INC 0.3%
Value $2.41M Shares 483,000 Est. Cost $10.31 Unrealized -54.7%
VTYX VENTYX BIOSCIENCES INC 0.1%
Value $677K Shares 316,195 Est. Cost $29.94 Unrealized -94.6%
JBIO JADE BIOSCIENCES INC 0.1%
Value $640K Shares 64,023 Est. Cost $33.31 Unrealized 0.0%
CABA CABALETTA BIO INC 0.0%
Value $132K Shares 86,795 Est. Cost $3.64 Unrealized -57.2%